Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT02484443
- NCI-2015-01001, NCI-2015-01001, AOST1421, U10CA180886
Trial sponsor
National Cancer Institute (NCI)
Scientific Title
A Phase 2 Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038) in Combination With Sargramostim (GM-CSF) in Patients With Recurrent Osteosarcoma